CHARLES SCHWAB INVESTMENT MANAGEMENT INC - AMNEAL PHARMACEUTICALS INC ownership

AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 168 filers reported holding AMNEAL PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of AMNEAL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$5,497,111
+41.3%
1,302,633
+3.8%
0.00%
+100.0%
Q2 2023$3,890,605
+141.6%
1,255,034
+8.3%
0.00%
Q1 2023$1,610,180
-32.4%
1,158,403
-3.2%
0.00%
-100.0%
Q4 2022$2,381,117
-0.9%
1,196,541
+0.6%
0.00%0.0%
Q3 2022$2,403,000
-35.2%
1,189,596
+2.0%
0.00%0.0%
Q2 2022$3,709,000
-24.7%
1,166,314
-1.2%
0.00%0.0%
Q1 2022$4,924,000
-11.5%
1,180,646
+1.6%
0.00%
-50.0%
Q4 2021$5,565,000
-9.1%
1,161,637
+1.3%
0.00%0.0%
Q3 2021$6,122,000
+9.0%
1,146,263
+4.5%
0.00%0.0%
Q2 2021$5,614,000
-5.9%
1,096,450
+23.8%
0.00%0.0%
Q1 2021$5,963,000
+79.0%
885,914
+21.6%
0.00%
+100.0%
Q4 2020$3,331,000
+17.9%
728,802
+0.1%
0.00%0.0%
Q3 2020$2,826,000
-21.4%
728,101
-3.6%
0.00%
-50.0%
Q2 2020$3,594,000
+46.1%
755,016
+6.8%
0.00%
+100.0%
Q1 2020$2,460,000
-26.2%
706,806
+2.2%
0.00%
-50.0%
Q4 2019$3,335,000
+104.6%
691,738
+23.1%
0.00%
+100.0%
Q3 2019$1,630,000
-67.8%
561,997
-20.4%
0.00%
-66.7%
Q2 2019$5,060,000
-46.9%
705,657
+4.9%
0.00%
-50.0%
Q1 2019$9,531,000
+19.2%
672,585
+13.8%
0.01%0.0%
Q4 2018$7,996,000
-35.4%
590,919
+6.0%
0.01%
-25.0%
Q3 2018$12,370,000
+81.2%
557,433
+34.0%
0.01%
+60.0%
Q2 2018$6,827,000416,0040.01%
Other shareholders
AMNEAL PHARMACEUTICALS INC shareholders Q4 2018
NameSharesValueWeighting ↓
Fosun International Ltd 21,521,301$83,503,0007.34%
Eversept Partners, LP 2,656,208$10,306,0872.29%
TPG Group Holdings (SBS) Advisors, Inc. 16,213,367$62,908,0001.13%
Prosight Management, LP 512,659$1,989,0000.95%
THB ASSET MANAGEMENT 833,104$3,232,0000.90%
GLOBEFLEX CAPITAL L P 251,696$977,0000.26%
XTX MARKETS LLC 10,243$40,0000.19%
HUSSMAN STRATEGIC ADVISORS, INC. 102,000$396,0000.10%
PA Capital LLC 33,874$132,0000.09%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 60,900$236,0000.07%
View complete list of AMNEAL PHARMACEUTICALS INC shareholders